High-pressure liquid chromatographic determination of ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus ftorafur.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Journal of Pharmacy and Science

• Publication date

  1980-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/JPS.2600691117PMID 6778988
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative determination of 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione and its metabolites in visceral tissues by high-performance liquid chromatography and gas chromatography-mass fragmentography.

  1980cited by this paper
• Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents.

  1979cited by this paper
• [Studies on the fate of 5-fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FD-1), a new antitumor agent. I. Absorption, distribution, excretion and metabolism of FD-1 administered orally to rats (author's transl)].

  1978cited by this paper
• Hydroxylated metabolies of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in rats and rabbits.

  1978cited by this paper
• Studies on antitumor agents, 2. Syntheses and antitumor activities of 1-(tetrahydro-2-furanyl)-5-fluorouracil and 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil.

  1978cited by this paper
• Quantitative determination of 1,3-bis(tetrahydro-2- furanyl)-5-fluoro-2,4-pyrimidinedione and its metabolites in plasma by high-pressure liquid chromatography and gas chromatography-mass fragmentography.

  1978cited by this paper
• Hydroxylated Metabolites of R,S-1-(Tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in Rats and Rabbits

  1978cited by this paper
• Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil.

  1978cited by this paper
• High-pressure liquid chromatographic analysis of ftorafur and its metabolites in biological fluids.

  1977cited by this paper
• Effect of N1-(2'-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on nucleic acid and protein biosyntheses in Ehrlich ascites cells.

  1976cited by this paper
• Determination of ftorafur and 5-fluorouracil levels in plasma and urine.

  1976cited by this paper

• Rapid determination of uracil in biological fluids at mercury thin film electrode for early detection of potential 5-fluorouracil toxicity due to dihydropyrimidine dehydrogenase deficiency.

  2024cites this paper
• Conclusion: Current Status and Future Developments

  2017cites this paper
• Copper solid amalgam electrode as a simple and sensitive tool for voltammetric determination of the antineoplastic drug 5-fluorouracil in pharmaceuticals

  2017cites this paper
• The achievement of mass balance by simultaneous quantification of floxuridine prodrug, floxuridine, 5-fluorouracil, 5-dihydrouracil, α-fluoro-β-ureidopropionate, α-fluoro-β-alanine using LC-MS.

  2011cites this paper
• A review of analytical methods for the determination of 5-fluorouracil in biological matrices

  2010cites this paper
• 5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil

  2008cites this paper
• Studies on the designing of chemotherapy for gastric cancer in man, based on the tumor tissue concentration of anticancer agents

  2007cites this paper
• Pharmacokinetics of gamma-hydroxybutylic acid (GHB) and gamma-butyrolactone (GBL), the anti-angiogenic metabolites of oral fluoropyrimidine UFT, in patients with gastric cancer.

  2007cites this paper
• Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma.

  2005cites this paper
• Pharmacokinetics of ftorafur after intravenous and oral administration

  2004cites this paper
• A pharmacodynamic and pharmacokinetic study of fluoropyrimidines in a nude mouse system and in postoperative patients with gastric cancer

  2004cites this paper
• Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.

  2004cites this paper
• UFT for head and neck cancers: its tissue concentrations and effects on lymphocyte subpopulations

  2004cites this paper
• Validated liquid chromatographic determination of 5-fluorouracil in human plasma.

  2004cites this paper
• Determination of 5-Fluorouracil and Its Prodrug Tegafur in Plasma and Tissue by High-Performance Liquid Chromatography in a Single Injection: Validation for Application in Clinical Pharmacokinetic Studies

  2003cites this paper
• Forced Expression of Cytidine Deaminase Confers Sensitivity to Capecitabine

  2003cites this paper
• Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.

  2002cites this paper
• Determination of the 5-fluorouracil and N1(2'-furanidyl)uracil in the presence of tegafur by zero-crossing first derivative spectrometry.

  2002cites this paper
• Stereoselective metabolism and pharmacokinetics of tegafur

  2001cites this paper
• A pharmacological study of the weekday-on/weekend-off oral UFT schedule in colorectal cancer patients

  2001cites this paper
• Multicenter randomized prospective study of adjuvant chemotherapy with UFT and mitomycin C in advanced colorectal cancer.

  2000cites this paper
• Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer

  2000cites this paper
• Differential growth inhibition by 5-fluorouracil in human colorectal carcinoma cell lines.

  2000cites this paper
• Preoperative UFT administration for patients with advanced colorectal cancer - increased uptake of 5-fluorouracil by tumor tissue is a prognostic factor

  2000cites this paper
• Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells.

  2000cites this paper
• Oral UFT (uracil plus futrafur) for neoadjuvant chemotherapy of gastric cancer

  1999cites this paper
• Therapeutic Effect of 1 M Tegafur‐0.4 M 5‐Chloro‐2,4‐dihydroxypyridine‐1 M Potassium Oxonate (S‐1) on Liver Metastasis of Xenotransplanted Human Colon Carcinoma

  1999cites this paper
• Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer

  1999cites this paper
• Neoadjuvant Chemotherapy of Gastric Cancer with UFT

  1999cites this paper
• Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.

  1998cites this paper
• Preliminary study on the optimal dosage schedule for oral tegafur/uracil (UFT) chemotherapy

  1998cites this paper
• Effects of the anticancer drug cocktail "UFT" on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model.

  1998cites this paper
• A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.

  1998cites this paper
• Neoadjuvant chemotherapy of gastric cancer with oral UFT (a mixture of uracil and fturafur) during the waiting period for surgery.

  1998cites this paper
• Simultaneous determination of 5-fluorouracil and uracil by high-performance liquid chromatography using four serial columns.

  1998cites this paper
• Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.

  1997cites this paper
• Determination of S-1 (combined drug of tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate) and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass spectrometry.

  1997cites this paper
• Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.

  1997cites this paper
• A pharmacological pilot study: application of an intermittent schedule of oral uracil and ftorafur (UFT) for hepatocellular carcinoma patients.

  1996cites this paper
• Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.

  1996cites this paper
• A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer

  1996cites this paper
• Antitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats

  1996cites this paper
• The antitumor effect of hyperthermia combined with fluorouracil and its analogues.

  1995cites this paper
• Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.

  1995cites this paper
• Potential of the histoculture drug-response assay to contribute to cancer patient survival.

  1995cites this paper
• Effect of gastrectomy on the pharmacokinetics of tegafur, uracil, and 5-fluorouracil after oral administration of a 1∶4 tegafur and uracil combination

  1994cites this paper
• Investigation of Thymidylate Synthase Induction in Colorectal Tissues after Administration of Anticancer Drug, Fluorinated Pyrimidine Fluoride Derivatives

  1993cites this paper
• Pharmacological Study of Continuously Infused Tegafur or 5-Fluorouracil in Treatments of Patients with Gastric Adenocarcinoma

  1993cites this paper
• Metabolism of Tegafur in Rat Liver Observed by in vivo 19F Magnetic Resonance Spectroscopy and Chromatography

  1992cites this paper
• Clinical pharmacology of combined oral uracil and ftorafur.

  1992cites this paper
• Metabolism of 1-(2‐tetrahydrofuryl)-5‐fluorouracil to 5‐fluorouracil in partially hepatectomized rats

  1992cites this paper
• Precolumn derivatization for the determination of fluoropyrimidines by liquid chromatography with chemiluminescence detection

  1990cites this paper
• High-performance liquid chromatography with chemiluminescence detection of serum levels of pre-column derivatized fluoropyrimidine compounds.

  1990cites this paper
• Combinative improving effect of increased solubility and the use of absorption enhancers on the rectal absorption of uracil in beagle dogs.

  1990cites this paper
• Influence of LC9018 on the Metabolism of Tegafur

  1990cites this paper
• The uptake of anticancer drugs by tumor tissues and lymph node and the effectiveness of postoperative adjuvant chemotherapy on survival time

  1989cites this paper
• Analysis of 5-fluorouracil in plasma by precolumn derivatization with 4-bromomethyl-7-methoxycoumarin, followed by multi-dimensional high-performance liquid chromatography.

  1989cites this paper
• PORTAL INFUSION CHEMOTHERAPY FOR UNRESECTABLE LIVER CANCER

  1989cites this paper
• High-performance liquid chromatography of 5-fluorouracil after derivatization with 4-bromomethyl-7-methoxycoumarin. Characterization of the derivative and the use of column switching for the improvement of resolution and the enhancement of sensitivity.

  1989cites this paper
• Analysis of 5-flourouracil in plasma by precolumn derivatization with 4-bromomethyl-7-methoxycoumarin, followed by multi-dimensional high-performance liquid chromatography

  1989cites this paper
• 4-Bromomethyl-6,7-dimethoxycoumarin as a fluorescence reagent for precolumn derivatization of 5-fluorouracil compounds in high-performance liquid chromatography.

  1988cites this paper
• Interactions between UFT and anticoagulants in lung cancer patients

  1988cites this paper
• Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma

  1987cites this paper
• Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumor.

  1987cites this paper
• Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1‐(2‐tetrahydrofuryl)‐5‐fluorouracil and uracil

  1987cites this paper
• Rapid analysis of 5-fluorouracil in plasma or formulations by high-performance liquid chromatography.

  1987cites this paper
• Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma.

  1985cites this paper
• Comparison of gas chromatographic/mass spectrometric and microbiological assays for 5-fluorouracil in plasma.

  1985cites this paper
• Clinical trials on UFT in the treatment of head and neck cancer.

  1985cites this paper
• [Quantitative method of 5-fluorouracil and its metabolites in biological samples using high performance liquid chromatography].

  1985cites this paper
• Prediction of ftorafur disposition in rats and man by a physiologically based pharmacokinetic model

  1985cites this paper
• 胃癌患者の術後補助化学療法における1-(2-tetrahydrofuryl)-5-fluorouracilのfat emulsion化によるリンパ移行性効果について

  1985cites this paper
• [High performance liquid chromatographic determination of pyrimidine nucleobases and 5-fluorouracil labeled with a fluorescent reagent].

  1984cites this paper
• Fluorescence determination of 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil in blood serum by high-performance liquid chromatography.

  1984cites this paper
• Cytochrome P-450-dependent oxidative cleavage of 1-(tetrahydro-2-furanyl)-5-fluorouracil to 5-fluorouracil.

  1984cites this paper
• Simultaneous determination of tegafur and 5-fluorouracil in serum by GLC using nitrogen-sensitive detection.

  1983cites this paper
• Improved liquid chromatographic assay for serum fluorouracil concentrations in the presence of ftorafur.

  1981cites this paper